ArticleFuture oncology (London, England)2026
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumors.
Ecaterina Dumbrava et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.